Citation 84165

MIN,BS: NAKAMURA,N: MIYASHIRO,H: KIM,YH: HATTORI,M:. (2000). INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE AND RIBONUCLEASE H ACTIVITIES BY CONSTITUENTS OF JUGLANS MANDSHURICA.. 48(2)

Citation Details

Title	INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE AND RIBONUCLEASE H ACTIVITIES BY CONSTITUENTS OF JUGLANS MANDSHURICA.
Authors	MIN,BS: NAKAMURA,N: MIYASHIRO,H: KIM,YH: HATTORI,M:
Year	2000
Volume	48
Issue	2

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Juglans mandshurica (JUGLANDACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-[ALPHA-L-ARABINOFURANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE]	None
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-[ALPHA-L-ARABINOFURANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
3	RNASE H INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-[ALPHA-L-ARABINOFURANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-[ALPHA-L-ARABINOFURANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
5	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-[ALPHA-L-ARABINOFURANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
6	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-GLUCOPYRANOSIDE	None
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
8	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)]-GLUCOPYRANOSIDE	None
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)]-GLUCOPYRANOSIDE	ACTIVE
11	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)]-GLUCOPYRANOSIDE	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)]-GLUCOPYRANOSIDE	None
13	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)]-GLUCOPYRANOSIDE	INACTIVE
14	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)]-GLUCOPYRANOSIDE	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)]-GLUCOPYRANOSIDE	None
16	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)]-GLUCOPYRANOSIDE	INACTIVE
17	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHALENE,1-4-8-TRIHYDROXY: 1-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)]-GLUCOPYRANOSIDE	INACTIVE
18	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)] GLUCOPYRANOSIDE	None
19	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)] GLUCOPYRANOSIDE	INACTIVE
20	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(4''-HYDROXY-3''-5''-DIMETHOXY-BENZOYL)] GLUCOPYRANOSIDE	INACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)] GLUCOPYRANOSIDE	None
22	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)] GLUCOPYRANOSIDE	ACTIVE
23	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-5''-DIHYDROXY-4''-METHOXY-BENZOYL)] GLUCOPYRANOSIDE	INACTIVE
24	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)] GLUCOPYRANOSIDE	None
25	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)] GLUCOPYRANOSIDE	ACTIVE
26	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRALONE,ALPHA: 4-ALPHA-5-8-TRIHYDROXY: 5-O-BETA-D-[6'-O-(3''-4''-5''-TRIHYDROXY-BENZOYL)] GLUCOPYRANOSIDE	ACTIVE
27	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	TAXIFOLIN	None
28	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
29	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
30	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	AFZELIN	None
31	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	INACTIVE
32	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	INACTIVE
33	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	QUERCITRIN	None
34	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	INACTIVE
35	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	INACTIVE
36	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	MYRICITRIN	None
37	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICITRIN	INACTIVE
38	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICITRIN	INACTIVE
39	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	GLUCOPYRANOSE,1-2-6-TRIGALLOYL:	None
40	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSE,1-2-6-TRIGALLOYL:	ACTIVE
41	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSE,1-2-6-TRIGALLOYL:	ACTIVE
42	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	GLUCOPYRANOSE,1-2-3-6-TETRAGALLOYL:	None
43	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSE,1-2-3-6-TETRAGALLOYL:	ACTIVE
44	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSE,1-2-3-6-TETRAGALLOYL:	ACTIVE

Citation 84165

Citation Details

Summary

Organisms and Their Experiments (1)

Juglans mandshurica (JUGLANDACEAE)

Show SPARQL Queries (1)

Query 1